Is NCT05519293 recruiting in Los Angeles, CA?

Yes, NCT05519293 is currently recruiting participants at its Los Angeles, CA location. This lung cancer clinical trial is actively enrolling qualified participants.

How do I join the lung cancer clinical trial in Los Angeles?

To join this clinical trial in Los Angeles, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Los Angeles clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Los Angeles, CANCT05519293Now EnrollingIRB Ready

Lung Cancer Clinical Trial in Los Angeles, CA

Access cutting-edge lung cancer treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Expert Care in Los Angeles

Access lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lung cancer treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this lung cancer clinical trial in Los Angeles, CA

Why Participate?

No-Cost Study Care
Local to Los Angeles
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

1Submit this form
2Phone screening
3Visit Los Angeles site if eligible
4Begin participation

About This Lung Cancer Study in Los Angeles

This is a phase I/IIa, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK and preliminary anti-tumor activity of H002 when given orally in patients with active EGFR mutation locally advanced or metastatic non-small cell lung cancer (NSCLC). The study will contain two parts: Part A is dose escalation phase (i.e., Phase I) and Part B is dose expansion phase (i.e., Phase IIa).

Sponsor: RedCloud Bio

Who Can Participate

Inclusion Criteria

Males or females aged ≥ 18 years at time of signing informed consent form (ICF). 2. Histological or cytological confirmed diagnosis of unresectable locally advanced or metastatic NSCLC. 3. Subjects must have NSCLC harboring one or more active EGFR mutations known to be associated with EGFR-TKI sensitivity (including, but not limited to Del19 and L858R).

Part A: All subjects may provide tumor sample to central laboratory to analyze the EGFR mutation status according to their own willingness;

Part B: All subjects must provide tumor sample to central laboratory to analyze the EGFR mutation status. And subjects must have NSCLC harboring EGFR C797S mutation. Note: Tumor sample can be either an archival sample or a sample obtained by pretreatment biopsy prior to H002 treatment. 4. Subjects must have radiological documented disease progression while on a previous continuous treatment with osimertinib or another third-generation EGFR-TKI as well as diseas

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT05519293) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lung Cancer Treatment Options in Los Angeles, CA

If you're searching for lung cancer treatment options in Los Angeles, CA, this clinical trial (NCT05519293) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Los Angeles, CA

See all lung cancer clinical trials recruiting in Los Angeles — not just this study.

Browse Lung Cancer Trials in Los Angeles →

Browse More Trials by Condition

Lung Cancer Trials Small Cell Lung Cancer Trials Non-Small Cell Lung Cancer Trials All Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA